A PHASE I, MULTICENTER, RANDOMIZED TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A RECOMBINANT VACCINIA-HIV ENVELOPE VACCINE (HIVAC-1E) IN COMBINATION WITH A PANEL OF SUBUNIT RECOMBINANT HIV ENVELOPE VACCINES: